Quest Diagnostics Incorporated (DGX) : Zacks Investment Research ranks Quest Diagnostics Incorporated (DGX) as 2, which is a Buy recommendation. 1 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. Not everyone is convinced about the stocks future, hence, the stock receives 1 Sell recommendation. 1 more believe that the stock has more downside risks, hence they propose a Strong Sell. A total of 13 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 16 research analysts is 3.02, which indicates as a Hold.
Quest Diagnostics Incorporated (DGX) : The highest level Quest Diagnostics Incorporated (DGX) is projected to reach is $84 for the short term and the lowest estimate is at $70. The consolidated price target from 12 rating analysts who initiate coverage on the stock is $75.58 and the possibility the share price can swing is $3.65.
Company shares have received an average consensus rating of Hold for the current week
Quest Diagnostics Incorporated (NYSE:DGX): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $83.02 and $82.48 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $83.29. The buying momentum continued till the end and the stock did not give up its gains. It closed at $83.01, notching a gain of 0.23% for the day. The total traded volume was 1,242,521 . The stock had closed at $82.82 on the previous day.
Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.